The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 07, 2020

Filed:

Dec. 15, 2015
Applicant:

The Johns Hopkins University, Baltimore, MD (US);

Inventors:

Jie Fu, Baltimore, MD (US);

Justin Hanes, Baltimore, MD (US);

Donald Jeffrey Zack, Baltimore, MD (US);

Zhiyong Yang, San Diego, CA (US);

Derek Stuart Welsbie, Lutherville, MD (US);

Cynthia Ann Berlinicke, Baltimore, MD (US);

Assignee:

The Johns Hopkins University, Baltimore, MD (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/404 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 9/19 (2006.01); A61K 31/506 (2006.01); A61K 9/51 (2006.01);
U.S. Cl.
CPC ...
A61K 31/404 (2013.01); A61K 9/0051 (2013.01); A61K 9/1647 (2013.01); A61K 9/19 (2013.01); A61K 9/5153 (2013.01); A61K 9/5192 (2013.01); A61K 31/506 (2013.01);
Abstract

Methods for increasing the encapsulation or incorporation of Sunitinib into polymeric matrices have been developed. The resulting formulations provide for more sustained controlled release of sunitinib or other inhibitors of JNK signaling, which bind to DLK. Increased loading is achieved using an alkaline solvent system. The pharmaceutical compositions can be administered to treat or reduce neuronal death due to elevated intraocular pressure. Upon administration, the sunitinib or other inhibitor is released over an extended period of time at concentrations which are high enough to produce therapeutic benefit, but low enough to avoid unacceptable levels of cytotoxicity, and which provide much longer release than inhibitor without conjugate.


Find Patent Forward Citations

Loading…